Plasma Lipopolysaccharide Concentrations in Cardiorenal Syndrome Type 1 | Zendy

Grazia Maria Virzì | Zendy; Andrea Breglia | Zendy; Ghada Ankawi | Zendy; Chiara Bolin | Zendy; Massimo de Cal | Zendy; Vito Cianci | Zendy; Giorgio Vescovo | Zendy; Claudio Ronco | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Plasma Lipopolysaccharide Concentrations in Cardiorenal Syndrome Type 1

Author(s) -

Grazia Maria Virzì,

Andrea Breglia,

Ghada Ankawi,

Chiara Bolin,

Massimo de Cal,

Vito Cianci,

Giorgio Vescovo,

Claudio Ronco

Publication year - 2019

Publication title -

cardiorenal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.661

H-Index - 21

eISSN - 1664-3828

pISSN - 1664-5502

DOI - 10.1159/000500480

Subject(s) - cardiorenal syndrome , medicine , acute kidney injury , cystatin c , creatinine , renal function , gastroenterology , acute decompensated heart failure , lipocalin , heart failure

Cardiorenal syndrome (CRS) type 1 is characterized by a rapid worsening of cardiac function that leads to acute kidney injury (AKI). This study evaluated the role of lipopolysaccharide (LPS) in the development of AKI in patients with acute heart failure (AHF) and its relationship with renal parameters, to enable a better comprehension of the pathophysiology of CRS type 1.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research